Stumpf v. Medical Benefits Administrators

179 F. Supp. 2d 1100, 26 Employee Benefits Cas. (BNA) 2431, 2001 U.S. Dist. LEXIS 20530, 2001 WL 1674803
CourtDistrict Court, D. Nebraska
DecidedSeptember 14, 2001
Docket8:99CV185
StatusPublished

This text of 179 F. Supp. 2d 1100 (Stumpf v. Medical Benefits Administrators) is published on Counsel Stack Legal Research, covering District Court, D. Nebraska primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Stumpf v. Medical Benefits Administrators, 179 F. Supp. 2d 1100, 26 Employee Benefits Cas. (BNA) 2431, 2001 U.S. Dist. LEXIS 20530, 2001 WL 1674803 (D. Neb. 2001).

Opinion

MEMORANDUM AND ORDER

BATAILLON, District Judge.

This matter comes before the court on cross motions for summary judgment. Filing Nos. 64 and 68. This is an action under the Employee Retirement Income Security Act, 29 U.S.C. § 1101, et seq. (ERISA). Plaintiff Faith White 1 filed this action for damages under ERISA, alleging that Stetson Building Products, Inc. (“Stetson”), Medical Benefit Administrators (“MBA”), and SAFECO breached fiduciary duties to her by denying payment of her pregnancy-related medical expenses. 2

*1103 Stetson moves for summary judgment. It asserts that the undisputed evidence shows that it did not abuse its discretion in denying White’s claim. White moves for partial summary judgment. She asserts that the undisputed evidence shows that Stetson breached its fiduciary duties under ERISA, but reserves the issue of damages. 3

I. Facts

The undisputed evidence shows that Faith White was an employee of Stetson Building Products, Inc. Stetson had an employee benefits plan under ERISA (the Plan). Stetson was the administrator of the Plan and had discretionary authority to administer it. Stetson contracted with Medical Benefits Administrators (MBA) to process claims under the Plan, and also contracted with SAFECO for excess loss coverage. Stetson’s contract with SAFE-CO provided that SAFECO would pay covered claims after Stetson paid a $10,000.00 deductible per individual employee. The Plan is self-funded, that is, all claims were to be paid out of Stetson’s general assets, subject to the excess loss contract with SAFECO.

White underwent an in vitro fertilization procedure (IVF) on March 13, 1998. The Plan excludes coverage for “services and supplies for or related to artificial insemination, in vitro fertilization, charges for donor ova or sperm, and other means of assisted reproduction.” White did not seek any reimbursement for the costs of that procedure. Ten days after the procedure, on March 23,1998, White was admitted to the emergency room at Rush Presbyterian Hospital in Chicago while on a business trip. She was diagnosed as having severe “ovarian hypersensitivity syndrome” (OHS) and was hospitalized from March 23, 1998, until April 1, 1998. During the hospitalization, she had a paracen-tesis 4 procedure in which nine liters of fluid were removed from her abdomen.

The hospital sought and obtained pre-certification for the admission from MBA. MBA referred the request to a company called Preferred Review for determination of whether the admission was medically necessary. The admission was certified as medically necessary and was monitored “day by day for [inpatient] necessity.” Exhibit A attached to Affidavit of Richard Bartolo. A March 25, 1998, notation in the clinical notes maintained by Preferred Review indicates “per Jane this is felt to be related to the embryo transplant” and later notes “the etiology of ovarian hyper-stimulation syndrome is related to the fertility drugs utilized with re: to embryo transplant — both of which are rx for infertility — of that question relates to benefit design.” Exhibit A at 3. On March 30, 1998, the clinical notes state “refer to PJW for maternity case evaluation].” Exhibit A at 4.

The discharge summary for the hospitalization lists White’s final diagnosis as “1. Ovarian hyperstimulation syndrome” and “2. History of an in vitro fertilization.” Defendant’s Exhibit 5. The discharge summary also states: “[o]n admission the patient’s beta HCG was 83” and “[b]eta HCG *1104 upon discharge was 568.” 5 Defendant’s Exhibit 5.

Pursuant to the Plan, White submitted a claim for the expenses of the hospitalization to Stetson’s third-party administrator, MBA, and the claims were denied. On August 17, 1998, MBA wrote to SAFECO (Stetson’s excess loss carrier) seeking SAEECO’s opinion, stating the issue as “whether the inpatient admission is directly related to the IYF procedure or if the charges were incurred for a related but eligible cause.” Defendant’s Exhibit 6. The inquiry noted, “[w]e are requesting this preliminary decision on whether the Chicago charges should be eligible” and further noted that “[t]his would put Ms. White into a reinsurance claim.” Defendant’s Exhibit 6. SAFECO responded, “[i]n our opinion ... the treatment rendered for during (sic) the inpatient admission ... was related to the in vitro fertilization — a direct result of the drug therapy used for the IVF” and that the expenses “would not be reimbursable in the event of an Excess Loss claim.” Defendant’s Exhibit 7. SAFECO offered to send the claim out for an outside physician review, and later did so. The outside physician responded that “[t]he ‘ovarian hyperstimulation syndrome’ described in the records is an unfortunate but well-known complication of ovarian hyperstimulation ... related to the in vitro fertilization,” but also noted, “[t]his patient’s pregnancy would be considered a direct result of the in vitro fertilization, which is done precisely for that purpose.” Defendant’s Exhibit 11.

White appealed the denial of coverage and, pursuant to the appeal process, sought a letter from her treating physician. Her treating physician, Dr. Victoria Maclin, wrote a letter to the MBA claims department on September 30,1998, stating that, “[w]hile it is indeed true that the patient was previously treated with fertility drugs, the fact that she did develop severe ovarian hyperstimulation syndrome was the result of the pregnancy that was established, and not simply because she had been previously treated with fertility drugs.” Defendant’s Exhibit 8. Dr. Maclin explained, “[i]t is only those patients who become pregnant who have development of this severe syndrome when it does occur.” Id. The Plan covers “maternity related expenses for a Covered Person.” Defendant’s Exhibit 2 at 25.

John Willmore is Stetson’s Chief Financial Officer and the Plan Administrator. He made the ultimate decision to deny benefits. He testified that, in making the decision, he relied on the opinions of MBA, SAFECO, and Stetson’s attorney, Roger Stetson. Defendant’s Exhibit 12, Deposition of John Willmore, at 10. He testified that he did not review any medical records from the Chicago hospitalization. Id. at 14. He further testified that he had no medical or science background, that he did not request any information or research on ovarian hyperstimulation syndrome, and that he did not contact or speak to any doctors, including WTiite’s treating physician. Id. at 3 & 14. Moreover, he testified that he had no knowledge of the documents or information on which either MBA or SAFECO relied in making their assessments. Id. at 46. Further, he testified that he did not know the educational background or professional experience of the physician who rendered the outside opinion. Id. at 54. He formed the opinion that WTiite’s claim was not covered after receiving Dr. Maclin’s letter, but discounted Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
179 F. Supp. 2d 1100, 26 Employee Benefits Cas. (BNA) 2431, 2001 U.S. Dist. LEXIS 20530, 2001 WL 1674803, Counsel Stack Legal Research, https://law.counselstack.com/opinion/stumpf-v-medical-benefits-administrators-ned-2001.